Osteogenesis Imperfecta - Fragile Bones


Published: 24 January 2019

Osteogenesis imperfecta (OI), which translates to ‘bones formed imperfectly’, is a rare genetic condition that causes bones to be fragile.

Due to its rarity, this can often mean that many nurses and other health professionals may have limited awareness, understanding and experience when caring for individuals with this condition (The OI Society of Australia 2019; Palomo et al. 2015).

Types of Osteogenesis Imperfecta

There are five main types of OI which range from mild to severe, with the mildest form of OI also being the most common. There are also many subgroups of these types.

Type 1 OI is the mildest form of OI, and may not be diagnosed until later in life, whereas the more severe types of OI can cause infant death during or shortly after birth, often by respiratory failure.

The 5 types of OI can be classified as follows:

OI Type 1: non-deforming OI with blue sclerae

  • This is the mildest form of OI and is characterised by increased bone fragility, blue sclerae and these individuals are also more susceptible to hearing loss.

OI Type 2: Perinatally lethal OI syndromes

  • This is the most severe and deadly type of OI. It is often detected at 18-20 weeks gestation and sadly, babies with this type of OI will rarely survive.

OI Type 3: Progressively deforming OI

  • OI will be present in these individuals from birth with bone fragility and multiple fractures leading to a progressive deformity of their skeleton. In the past, many individuals with this type of OI wouldn’t survive into adulthood due to complications of skeletal chest wall deformity causing pulmonary hypertension, cardio-respiratory failure and kyphoscoliosis, however, with current therapeutic options, these individuals are now surviving into adulthood.

OI Type 4: Common variable OI

  • These patients have recurrent fractures, osteoporosis and deformity of both the long bones and spine, but will have normal sclerae by the time they reach late childhood.

OI Type 5: OI with calcification in interosseous membranes

  • This type of OI is indicated by moderate to severe bone fragility with progressive calcification of the inter-osseous membranes in the forearm and legs

(The OI Society of Australia 2019; Van Dijk & Sillence 2014)

The severity grading of each relies on assessing the individual’s clinical data, historical data, the frequency of their fractures, bone density and their level of mobility. Statistically, however, approximately only 7 people per 100,000 people are born with any type of OI (The OI Society of Australia 2019; US National Library of Medicine 2018; Van Dijk & Sillence 2014).

Osteogenesis Imperfecta Type V in Adult

Osteogenesis Imperfecta Type V in Adult (CC 2010, ShakataGaNai)


Causes of Osteogenesis Imperfecta

OI is caused by a mutation in one of the two genes that produce collagen. It causes the person to have either a decreased amount of collagen or poorer quality collagen, which then causes their bones to be weak and consequently fracture more easily.

The mutated gene can be inherited from one or both parents or can be the result of a new and random mutation. It is important to note that parents of a child with OI often will not display OI themselves (The OI Society of Australia 2019; Van Dijk & Sillence 2014).

Osteogenesis Imperfecta Diagnosis

Diagnosis occurs as a result of investigations being undertaken due to a child having frequent multiple fractures. As well as fractures, diagnostic signs, symptoms and consequent tests include:

  • Blue sclerae: note that this is not present in all types of OI;
  • Opalescent teeth: not present in all types of OI;
  • Family history: however, in many cases of OI, there will be no family history of OI;
  • Blood tests: these include calcium, phosphorus and serum alkaline phosphate. Blood tests are important in order to exclude other causes;
  • Urine tests: these allow determination of the level of bone breakdown and turnover occurring;
  • X-rays: many OI patients will have Wormian bones, which are extra bones present in the person’s skull;
  • Bone density scans;
  • Genetic testing: uncommon, due to the cost and how time-consuming the tests can be.

(The OI Society of Australia 2019)

How Does Osteogenesis Imperfecta Present?

People with OI will often be of short stature, have blue tinted sclerae, some form of hearing loss, brittle teeth, muscle weakness, hypermobility and potentially progressive skeletal deformity and restricted breathing.

Many of them will also be diagnosed with osteoporosis. There can also be cardiovascular effects related to OI, which are usually reported in adults rather than children. These may include forms of valve dysfunction and aortic root dilation.

Another implication for adults over 40 years of age with OI is that more than 50% of sufferers will also have some form of hearing impairment. Experiences of vertigo can also be quite common (The OI Society of Australia 2019; Palomo et al. 2015; Van Dijk & Sillence 2014).

Nursing considerations for individuals with OI need to include not only the connective tissue and bone deformities characterised by this condition but also the consequential effects of the condition, such as vertigo.

Pain is also often present in individuals with OI and when uncontrolled, can negatively impact the individual’s quality of life.

It is important to note that depending on which type of OI the individual has, they may experience different symptoms to an individual with another type. There will be many common variables between the types, although some symptoms are more common in certain types of OI then others.

Therefore, if you are a nurse caring for someone with OI, it is important to determine which type of OI they have and what symptoms they display, as everyone can be affected by different symptoms of this condition (US National Library of Medicine 2018; Van Dijk & Sillence 2014).

Treating Osteogenesis Imperfecta

As a genetic condition, OI will often affect many of the body systems and cannot be cured. Therefore treatment is aimed to manage some of the associated signs and symptoms.

One of these treatments includes intravenous bisphosphonate therapy which will help treat bone fragility and can increase bone density and decrease the fracture rates of the long bones in children with OI. (Palomo et al. 2015; US National Library of Medicine 2018).

The implementation of management strategies for individuals with OI is also an important part of treatment. Therefore, the nurses’ role needs to not only focus on assisting with treatment strategies but also management strategies in areas such as pain, mobility, hearing impairment and any modifications to maintain the individuals quality of life with this condition.